A role for the androgen metabolite, 5α-Androstane-3β, 17β-Diol, in modulating oestrogen receptor β-mediated regulation of hormonal stress reactivity

Journal of Neuroendocrinology

Volumn 21, Issue 4, 2009, Pages 351-358

  Handa, Robert J ^a,b   Weiser, M J ^a   Zuloaga, D G ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

17 diol; 5 androstane 3 ; ACTH; Androgen; Corticosterone; Dihydrotestosterone; Oestrogen receptor ; Oestrogen response element; Vasopressin

Indexed keywords

3BETA ANDROSTANEDIOL; ANDROGEN; ANDROGEN RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NEUROPEPTIDE; OXYTOCIN; TESTOSTERONE;

ADENOHYPOPHYSIS; ANDROGEN METABOLISM; AROMATIZATION; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR DISORDER; CONFERENCE PAPER; DRUG RESEARCH; ESTROGEN BINDING; GENE EXPRESSION; HEMOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HORMONE INHIBITION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HORMONE RESPONSE; HORMONE STRUCTURE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STRESS;

ANDROGENS; ANDROSTANE-3,17-DIOL; ANIMALS; ESTROGEN RECEPTOR BETA; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEURONS; OXYTOCIN; PITUITARY-ADRENAL SYSTEM; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 63549119167     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2009.01840.x     Document Type: Conference Paper

References (98)

1. Naftolin F, Ryan KJ, Davies IJ, Reddy VV, Flores F, Petro Z, Kuhn M, White RJ, Takaoka Y, Wolin L. The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res 1975; 31: 295-319.
2. Selmanoff MK, Brodkin LD, Weiner RI, Siiteri PK. Aromatization and 5alpha-reduction of androgens in discrete hypothalamic and limbic regions of the male and female rat. Endocrinology 1977; 101: 841-848.
3. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269-301.
4. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17: 187-205.
5. Gaskin JH, Kitay JI. Adrenocortical function in the hamster. Sex differences and effects of gonadal hormones. Endocrinology 1970; 87: 779-786.
6. Handa RJ, Burgess LH, Kerr JE, O'Keefe JA. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 1994; 28: 464-476.
7. Burgess LH, Handa RJ. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 1992; 131: 1261-1269.
8. McCormick CM, Linkroum W, Sallinen BJ, Miller NW. Peripheral and central sex steroids have differential effects on the HPA axis of male and female rats. Stress 2002; 5: 235-247.
9. Kitay JI. Depression of adrenal corticosterone production in oophorectomized rats. Endocrinology 1965; 77: 1048-1052.
10. Coyne MD, Kitay JI. Effect of ovariectomy on pituitary secretion of ACTH. Endocrinology 1969; 85: 1097-1102.
11. Coyne MD, Kitay JI. Effect of orchiectomy on pituitary secretion of ACTH. Endocrinology 1971; 89: 1024-1028.
12. Viau V, Meaney MJ. Testosterone-dependent variations in plasma and intrapituitary corticosteroid binding globulin and stress hypothalamic-pituitary-adrenal activity in the male rat. J.Endocrinol 2004; 181: 223-231.
13. Handa RJ, Nunley KM, Lorens SA, Louie JP, McGivern RF, Bollnow MR. Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors. Physiol Behav 1994; 55: 117-124.
14. Lund TD, Hinds LR, Handa RJ. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J. Neurosci 2006; 26: 1448-1456.
15. Viau V, Lee P, Sampson J, Wu J. A testicular influence on restraint-induced activation of medial parvocellular neurons in the paraventricular nucleus in the male rat. Endocrinology 2003; 144: 3067-3075.
16. Viau V, Meaney MJ. The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic area. J. Neurosci 1996; 16: 1866-1876.
17. Lund TD, Munson DJ, Haldy ME, Handa RJ. Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse. Neurosci Lett 2004; 365: 43-47.
18. Kerr JE, Beck SG, Handa RJ. Androgens selectively modulate C-fos messenger RNA induction in the rat hippocampus following novelty. Neuroscience 1996; 74: 757-766.
19. Lund TD, Munson DJ, Haldy ME, Handa RJ. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol 2004; 16: 272-278.
20. Romeo RD, Bellani R, Karatsoreos IN, Chhua N, Vernov M, Conrad CD, McEwen BS. Stress history and pubertal development interact to shape hypothalamic-pituitary-adrenal axis plasticity. Endocrinology 2006; 147: 1664-1674.
21. Viau V, Bingham B, Davis J, Lee P, Wong M. Gender and puberty interact on the stress-induced activation of parvocellular neurosecretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology 2005; 146: 137-146.
22. Romeo RD, Lee SJ, Chhua N, McPherson CR, McEwen BS. Testosterone cannot activate an adult-like stress response in prepubertal male rats. Neuroendocrinology 2004; 79: 125-132.
23. He WW, Kumar MV, Tindall DJ. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse. Nucleic Acids Res 1991; 19: 2373-2378.
24. Yarbrough WG, Quarmby VE, Simental JA, Joseph DR, Sar M, Lubahn DB, Olsen KL, French FS, Wilson EM. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J. Biol Chem 1990; 265: 8893-8900.
25. Zuloaga DG, Morris JA, Jordan CL, Breedlove SM. Mice with the testicular feminization mutation demonstrate a role for androgen receptors in the regulation of anxiety-related behaviors and the hypothalamic-pituitary-adrenal axis. Horm Behav 2008; 54: 758-766.
26. Bingaman EW, Magnuson DJ, Gray TS, Handa RJ. Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy. Neuroendocrinology 1994; 59: 228-234.
27. Bingham B, Williamson M, Viau V. Androgen and estrogen receptor-beta distribution within spinal-projecting and neurosecretory neurons in the paraventricular nucleus of the male rat. J. Comp Neurol 2006; 499: 911-923.
28. Suzuki S, Lund TD, Price RH, Handa RJ. Sex differences in the hypothalamo-pituitary-adrenal axis: Novel roles for androgen and estrogen receptors. Recent Res Dev Endocrinol 2001; 2: 69-86.
29. Zhou L, Blaustein JD, De Vries GJ. Distribution of androgen receptor immunoreactivity in vasopressin- and oxytocin-immunoreactive neurons in the male rat brain. Endocrinology 1994; 134: 2622-2627.
30. Bingaman EW, Baeckman LM, Yracheta JM, Handa RJ, Gray TS. Localization of androgen receptor within peptidergic neurons of the rat forebrain. Brain Res Bull 1994; 35: 379-382.
31. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol 2008; 29: 169-181.
32. Beato M. Gene regulation by steroid hormones. Cell 1989; 56: 335-344.
33. Beato M, Klug J. Steroid hormone receptors: An update. Hum Reprod Update 2000; 6: 225-236.
34. Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, Tran MG, Neal DE, Mills IG. New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 2007; 8: 871-878.
35. Kim K, Barhoumi R, Burghardt R, Safe S. Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol Endocrinol 2005; 19: 843-854.
36. Price RH, Jr, Butler CA, Webb P, Uht R, Kushner P, Handa RJ. A splice variant of estrogen receptor beta missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation. Endocrinology 2001; 142: 2039-2049.
37. Webb P, Lopez GN, Uht RM, Kushner PJ. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995; 9: 443-456.
38. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925-5930.
39. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp Neurol 1997; 388: 507-525.
40. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: Anatomical evidence of distinct roles of each subtype. J. Neurobiol 1998; 36: 357-378.
41. Shughrue PJ, Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J. Comp Neurol 2001; 436: 64-81.
42. Suzuki S, Handa RJ. Regulation of estrogen receptor-beta expression in the female rat hypothalamus: Differential effects of dexamethasone and estradiol. Endocrinology 2004; 145: 3658-3670.
43. Alves SE, Lopez V, McEwen BS, Weiland NG. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: An immunocytochemical study. Proc Natl Acad Sci USA 1998; 95: 3281-3286.
44. Hrabovszky E, Kallo I, Hajszan T, Shughrue PJ, Merchenthaler I, Liposits Z. Expression of estrogen receptor-beta messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei. Endocrinology 1998; 139: 2600-2604.
45. Somponpun SJ, Sladek CD. Depletion of oestrogen receptor-beta expression in magnocellular arginine vasopressin neurones by hypovolaemia and dehydration. J. Neuroendocrinol 2004; 16: 544-549.
46. Suzuki S, Handa RJ. Estrogen receptor-beta, but not estrogen receptor-alpha, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: Comparison with other neuropeptides. J. Comp Neurol 2005; 484: 28-42.
47. Miller WJ, Suzuki S, Miller LK, Handa R, Uht RM. Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway. J. Neurosci 2004; 24: 10628-10635.
48. Estacio MA, Yamada S, Tsukamura H, Hirunagi K, Maeda K. Effect of fasting and immobilization stress on estrogen receptor immunoreactivity in the brain in ovariectomized female rats. Brain Res 1996; 2: 55-61.
49. Simerly RB, Young BJ. Regulation of estrogen receptor messenger ribonucleic acid in rat hypothalamus by sex steroid hormones. Mol Endocrinol 1991; 5: 424-432.
50. Weiser MJ, Handa RJ. Estrogen impairs glocococricoid dependent negative feedback on the hypothalamic-pitoitacy-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009; Jan [Epub ahead of print].
51. Roselli CE, Horton LE, Resko JA. Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology 1985; 117: 2471-2477.
52. Lephart ED, Lund TD, Horvath TL. Brain androgen and progesterone metabolizing enzymes: Biosynthesis, distribution and function. Brain Res Brain Res Rev 2001; 3: 25-37.
53. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
54. Handa RJ, Stadelman HL, Resko JA. Effect of estrogen on androgen receptor dynamics in female rat pituitary. Endocrinology 1987; 121: 84-89.
55. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863-870.
56. Gangloff A, Shi R, Nahoum V, Lin SX. Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase. FASEB J 2003; 17: 274-276.
57. Jin Y, Penning TM. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: Key enzymes in androgen metabolism. Best Pract Res Clin Endocrinol Metab 2001; 15: 79-94.
58. Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, Penning TM. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: Implications for steroid hormone metabolism and action. J. Biol Chem 2004; 279: 10784-10795.
59. Torn S, Nokelainen P, Kurkela R, Pulkka A, Menjivar M, Ghosh S, Coca-Prados M, Peltoketo H, Isomaa V, Vihko P. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun 2003; 305: 37-45.
60. Weihua Z, Lathe R, Warner M, Gustafsson JA. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 2002; 99: 13589-13594.
61. Fernandez-Guasti A, Martinez-Mota L. Anxiolytic-like actions of testosterone in the burying behavior test: Role of androgen and GABA-benzodiazepine receptors. Psychoneuroendocrinology 2005; 30: 762-770.
62. Reddy DS. Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol. Neuroreport 2004; 15: 515-518.
63. Rosellini RA, Svare BB, Rhodes ME, Frye CA. The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate the effects of testosterone on conditioned place preference. Brain Res Brain Res Rev 2001; 3: 162-171.
64. Rupprecht R, Holsboer F. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 1999; 22: 410-416.
65. Bauman DR, Steckelbroeck S, Williams MV, Peehl DM, Penning TM. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: A potential therapeutic target for androgen-dependent disease. Mol Endocrinol 2006; 20: 444-458.
66. Sundin M, Warner M, Haaparanta T, Gustafsson JA. Isolation and catalytic activity of cytochrome P-450 from ventral prostate of control rats. J. Biol Chem 1987; 262: 12293-12297.
67. Guennoun R, Fiddes RJ, Gouezou M, Lombes M, Baulieu EE. A key enzyme in the biosynthesis of neurosteroids, 3 beta-hydroxysteroid dehydrogenase/ delta 5-delta 4-isomerase (3 beta-HSD), is expressed in rat brain. Brain Res Mol Brain Res 1995; 30: 287-300.
68. Somponpun SJ, Holmes MC, Seckl JR, Russell JA. Modulation of oestrogen receptor-beta mRNA expression in rat paraventricular and supraoptic nucleus neurones following adrenal steroid manipulation and hyperosmotic stimulation. J. Neuroendocrinol 2004; 16: 472-482.
69. Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ. Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 2003; 121: 837-845.
70. Pak T, Chung W, Handa R. Estrogen receptor-beta mediates DHT-induced stimulation of the arginine vasopressinpromoter in neuronal cells. Endocrinology 2007; 148: 3371-3382.
71. Pettersson K, Delauney F, Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000; 19: 4970-4978.
72. Dellovade TL, Zhu YS, Pfaff DW. Thyroid hormones and estrogen affect oxytocin gene expression in hypothalamic neurons. J. Neuroendocrinol 1999; 11: 1-10.
73. Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S. Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol Brain Res 2002; 2: 84-94.
74. Shughrue PJ, Dellovade TL, Merchenthaler I. Estrogen modulates oxytocin gene expression in regions of the rat supraoptic and paraventricular nuclei that contain estrogen receptor-beta. Prog Brain Res 2002; 13: 915-929.
75. Patisaul HB, Scordalakes EM, Young LJ, Rissman EF. Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus. J. Neuroendocrinol 2003; 15: 787-793.
76. Neumann ID, Kromer SA, Toschi N, Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul Pept 2000; 2: 31-38.
77. Neumann ID, Wigger A, Torner L, Holsboer F, Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: Partial action within the paraventricular nucleus. J. Neuroendocrinol 2000; 12: 235-243.
78. Windle RJ, Shanks N, Lightman SL, Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997; 138: 2829-2834.
79. Windle RJ, Gamble LE, Kershaw YM, Wood SA, Lightman SL, Ingram CD. Gonadal steroid modulation of stress-induced hypothalamo-pituitary-adrenal activity and anxiety behavior: Role of central oxytocin. Endocrinology 2006; 147: 2423-2431.
80. Ochedalski T, Subburaju S, Wynn PC, Aguilera G. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol 2007; 19: 189-197.
81. Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J. Neurosci 2004; 24: 2974-2982.
82. Muir JL, Brown R, Pfister HP. A possible role for oxytocin in the response to a psychological stressor. Pharmacol Biochem Behav 1986; 25: 107-110.
83. Petersson M, Hulting AL, Uvnas-Moberg K. Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett 1999; 3: 41-44.
84. Mantella RC, Vollmer RR, Rinaman L, Li X, Amico JA. Enhanced corticosterone concentrations and attenuated Fos expression in the medial amygdala of female oxytocin knockout mice exposed to psychogenic stress. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1494-R1504.
85. Hisano S, Fukui Y, Chikamori-Aoyama M, Aizawa T, Shibasaki T. Reciprocal synaptic relations between CRF-immunoreactive- and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus. Brain Res 1993; 620: 343-346.
86. Inenaga K, Yamashita H. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin. J. Physiol 1986; 370: 165-180.
87. 3 H]Oxytocin binding sites in the rat brain demonstrated by quantitative light microscopic autoradiography. Eur J Pharmacol 1984; 102: 365-367.
88. Freund-Mercier MJ, Stoeckel ME. Somatodendritic autoreceptors on oxytocin neurones. Adv Exp Med Biol 1995; 395: 185-194.
89. Nishioka T, Anselmo-Franci JA, Li P, Callahan MF, Morris M. Stress increases oxytocin release within the hypothalamic paraventricular nucleus. Brain Res 1998; 2: 56-60.
90. Engelmann M, Ebner K, Landgraf R, Holsboer F, Wotjak CT. Emotional stress triggers intrahypothalamic but not peripheral release of oxytocin in male rats. J. Neuroendocrinol 1999; 11: 867-872.
91. Wotjak CT, Ganster J, Kohl G, Holsboer F, Landgraf R, Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons. Neuroscience 1998; 85: 1209-1222.
92. Ludwig M, Leng G. Intrahypothalamic vasopressin release. An inhibitor of systemic vasopressin secretion? Adv Exp Med Biol 1998; 449: 163-173.
93. Buijs RM, Swaab DF. Immuno-electron microscopical demonstration of vasopressin and oxytocin synapses in the limbic system of the rat. Cell Tissue Res 1979; 204: 355-365.
94. Voorn P, Buijs RM. An immuno-electronmicroscopical study comparing vasopressin, oxytocin, substance P and enkephalin containing nerve terminals in the nucleus of the solitary tract of the rat. Brain Res 1983; 270: 169-173.
95. Landgraf R, Malkinson T, Horn T, Veale WL, Lederis K, Pittman QJ. Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am J Physiol 1990; 2: R155-R159.
96. Stern JE, Zhang W. Preautonomic neurons in the paraventricular nucleus of the hypothalamus contain estrogen receptor beta. Brain Res 2003; 2: 99-109.
97. Kerman IA, Akil H, Watson SJ. Rostral elements of sympatho-motor circuitry: A virally mediated transsynaptic tracing study. J. Neurosci 2006; 26: 3423-3433.
98. Strack AM, Sawyer WB, Platt KB, Loewy AD. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 1989; 491: 274-296.